James M. Frates, CFO: Amylyx Pharmaceuticals AMLX Buy · Filed 24/09/16

Trade details

Type: Insider buy
Amount: $101,200
Shares · price: 40,000 sh · $2.53 a share
Held after: 233,464 sh
Stock: Amylyx Pharmaceuticals AMLX
Person: James M. FratesCFO
Trade date: 24/09/12
Filed: 24/09/16
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +20.7%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/08/13~24/10/12

James M. Frates's recent trades

James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$349.8K
10,810 sh
$349.8K
Filed 09/11
Traded 09/10
James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$114.8K
7,909 sh
$114.8K
Filed 03/04
Traded 03/02
James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$114.9K
7,909 sh
$114.9K
Filed 03/02
Traded 03/02
James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$52.1K
3,557 sh
$52.1K
Filed 02/04
Traded 02/02
James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$52.1K
3,557 sh
$52.1K
Filed 02/02
Traded 02/02